The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration

被引：0
|
作者：
Luca Afferi
Stefania Zamboni
R. Jeffrey Karnes
Florian Roghmann
Paul Sargos
Francesco Montorsi
Alberto Briganti
Andrea Gallina
Agostino Mattei
Gerald Bastian Schulz
Kees Hendricksen
Charlotte S. Voskuilen
Michael Rink
Cedric Poyet
Ottavio De Cobelli
Ettore di Trapani
Claudio Simeone
Matteo Soligo
Giuseppe Simone
Gabriele Tuderti
Mario Alvarez-Maestro
Luis Martínez-Piñeiro
Atiqullah Aziz
Shahrokh F. Shariat
Mohammad Abufaraj
Evanguelos Xylinas
Marco Moschini
机构：
[1] Luzerner Kantonsspital,Department of Urology
[2] University of Brescia,Department of Urology, Spedali Civili Hospital
[3] Mayo Clinic Urology,Department of Urology, Marien Hospital
[4] Ruhr-University Bochum,Department of Radiation Oncology, Jewish General Hospital
[5] McGill University Health Centre,Department of Urology, Urological Research Institute, San Raffaele Scientific Institute
[6] Vita-Salute University,Urologische Klinik Und Poliklinik, Klinikum Der Universität München
[7] Ludwig-Maximilians-Universität München,Department of Urology
[8] Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital,Department of Urology
[9] University Medical Center Hamburg-Eppendorf,Department of Urology, University Hospital Zürich
[10] University of Zürich,Division of Urology
[11] European Institute of Oncology,Department of Urology
[12] IRCCS “Regina Elena” National Cancer Institute,Department of Urology
[13] La Paz University Hospital,Department of Urology
[14] Instituto de Investigación Hospital Universitario La Paz (IdiPAZ),Department of Urology, Comprehensive Cancer Center, Vienna General Hospital
[15] München Klinik Bogenhausen,Institute for Urology and Reproductive Health
[16] Medical University of Vienna,Department of Urology
[17] I.M. Sechenov First Moscow State Medical University,Department of Urology
[18] Weill Cornell Medical College,Department of Urology, Second Faculty of Medicine
[19] New York-Presbyterian Hospital,Division of Urology, Department of Special Surgery, Jordan University Hospital
[20] University of Texas Southwestern Medical Center,The National Center for Diabetes, Endocrinology and Genetics
[21] Charles University,Department of Urology Bichat Hospital
[22] The University of Jordan,undefined
[23] The University of Jordan,undefined
[24] Paris Descartes University,undefined
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Bladder cancer; Clinical metastases; Induction chemotherapy; Multimodal treatment; Radical cystectomy; Urothelial cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：443 / 451
页数：8
相关论文
共 50 条
  • [31] THE IMPACT OF LYMPH NODE DENSITY ON OUTCOME IN LYMPH NODE-POSITIVE CERVICAL CANCER PATIENTS
    Yoon, A.
    Lee, Y. Y.
    Kim, T. H.
    Choi, J. K.
    Yoon, G. U. N.
    Kim, T. J.
    Lee, J. W.
    Kim, B. G.
    Bae, D. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 562 - 562
  • [32] Survival outcomes with radical cystectomy (RC) in localized clinically node-positive bladder cancer (CNBC).
    Perimbeti, Stuthi
    Jiang, Changchuan
    Deng, Lei
    Jatwani, Karan
    Kaur, Anahat
    George, Saby
    Chatta, Gurkamal S.
    Gopalakrishnan, Dharmesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [33] Survival Benefit of Radical Prostatectomy in Lymph Node-Positive Patients with Prostate Cancer
    Engel, Jutta
    Bastian, Patrick J.
    Baur, Helmut
    Beer, Volker
    Chaussy, Christian
    Gschwend, Juergen E.
    Oberneder, Ralph
    Rothenberger, Karl H.
    Stief, Christian G.
    Hoelzel, Dieter
    EUROPEAN UROLOGY, 2010, 57 (05) : 754 - 761
  • [34] Survival Benefit of Trimodality Therapy in Lymph Node-Positive Patients with Esophageal Cancer
    Park, J.
    Kim, W.
    Kim, H.
    Gwak, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S321 - S321
  • [35] Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
    Yilun Li
    Li Ma
    BMC Cancer, 21
  • [36] Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
    Li, Yilun
    Ma, Li
    BMC CANCER, 2021, 21 (01)
  • [37] Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis
    Joshi, Shreyas S.
    Handorf, Elizabeth
    Strauss, David
    Correa, Andres F.
    Kutikov, Alexander
    Chen, David Y. T.
    Viterbo, Rosalia
    Greenberg, Richard E.
    Uzzo, Robert G.
    Smaldone, Marc C.
    Geynisman, Daniel M.
    JAMA ONCOLOGY, 2018, 4 (05) : 643 - 649
  • [38] Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients
    Ottevanger, PB
    De Mulder, PHM
    Grol, RPTM
    van Lier, H
    Beex, LVAM
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (02) : 198 - 204
  • [39] What Is the Optimal Treatment for Patients With Sentinel Node-Positive Vulvar Cancer?
    Han, K.
    Louie, A. V.
    Marchand, E.
    Leung, E. W.
    Milosevic, M.
    Fyles, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S503 - S503
  • [40] Role of adjuvant chemotherapy in the treatment of patients with node-positive bladder adenocarcinoma: An analysis of the National Cancer Database.
    Reddy, Akshay G.
    Sparks, Andrew D.
    Whalen, Michael Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345